{
    "nctId": "NCT00619762",
    "briefTitle": "Immediate Postmastectomy Breast Reconstruction (Strattice Breast)",
    "officialTitle": "A Multicenter, Prospective, Open-Label Study to Assess the Clinical Outcomes of LTM Use in Two-Stage Breast Reconstruction Immediately Post Mastectomy",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 17,
    "primaryOutcomeMeasure": "Histology Sample Evaluations Assessing Incorporation of StratticeTM Reconstructive Tissue Matrix",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* A candidate for immediate, two-stage breast reconstruction using LTM following a skin sparing mastectomy\n* An ASA Physical Status Classification5 of 1 or 2 (see App I)\n* Estimated life expectancy \\> 1 year\n\nExclusion Criteria:\n\n* Clinically significant systemic disease\n* Received inductive chemo-therapy within 2 months prior to mastectomy or radiation therapy to the region at any time\n* Predicted excised breast mass of \\>750 gms\n* Co-morbid factors which predispose to postoperative infection, such as insulin dependent diabetes, smoking, chronic steroid use, malnourishment, or co-existent infection\n* Need for tissue flap in addition to expander\n* History of alcohol abuse, illicit drug use, significant mental illness, physical dependence to any opioid, or drug abuse or addiction\n* Enrollment or plans to enroll in another clinical trial during this study that would affect the patient's safety or results of this trial\n* Any of the conditions identified within the labeled contraindications, i.e. sensitivity to porcine derived products or polysorbate",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}